Tech Company Financing Transactions
Cyrus Biotechnology Funding Round
Trinity Ventures, OrbiMed and SpringRock Ventures participated in a $8 million Series A funding round for Cyrus Biotechnology. The round was announced on 7/28/2017.
Transaction Overview
Company Name
Announced On
7/28/2017
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Investors
Proceeds Purpose
The new funding validates our business plan and allows us to expand the capabilities and opportunities of this cutting-edge platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
500 Union St. 320
Seattle, WA 98101
USA
Seattle, WA 98101
USA
Phone
Website
Email Address
Overview
Cyrus Biotechnology, Inc. is a privately-held biotechnology software company offering protein modeling and design capabilities to the biopharmaceutical, chemical, consumer products and synthetic biology industries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lucas Nivon
Chief Scientific Officer
Yifan Song
Co-Founder
David Baker
President
Mark Benjamin
VP - Sales
Rosario Caltabiano
Browse more venture capital transactions:
Prev: 7/28/2017: SyncHR venture capital transaction
Next: 7/28/2017: Megacool venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs